| 2002 | | H. pylori Infection and Gastric Carcinogenesis | 김명욱, 김영배, 김진홍, 이기명, 정재연, 조성원, 조용관, 주희재, 최준혁, 한상욱, 함기백 |
| 2012 | | Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection | 강석윤, 김영배, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최진혁, 한상욱, 한재호 |
| 2002 | | Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. | 김명욱, 김영배, 조용관, 주희재, 한상욱, 함기백 |
| 2003 | | Long-term evaluation of mice model infected with Helicobacter pylori: focus on gastric pathology including gastric cancer. | 김명욱, 김영배, 김진홍, 조성원, 조용관, 주희재, 한상욱, 함기백 |
| 1997 | | Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection. | 김진홍, 이광재, 임현이, 조성원, 함기백 |
| 1998 | | Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori. | 김영수, 김진홍, 이광재, 임현이, 조성원, 주희재, 함기백 |
| 2021 | | Risk factor-based optimal endoscopic surveillance intervals after endoscopic submucosal dissection for gastric adenoma | 김영배, 노진, 노충균, 박범희, 신성재, 이기명, 이길호, 임선교 |
| 2005 | | Synergism of Helicobacter pylori infection and stress on the augmentation of gastric mucosal damage and its prevention with alpha-tocopherol. | 김영배, 여말희, 조성원, 조용관, 한상욱, 함기백 |
| 2004 | | The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. | 김영배, 한상욱, 함기백 |
